A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
Clinical trial NCT06176352 · COMPLETED
Trial details
- NCT number
- NCT06176352
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-06
- Primary completion
- 2026-05-22
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.